What happens when you take lovastatin with niacin?
Lovastatin is a statin that lowers LDL cholesterol. Niacin (nicotinic acid) is vitamin B3. In large amounts, 1 gram a day or more, niacin is also used to change blood fats, either as a prescription (such as Niaspan) or as a high-strength supplement. Lovastatin can injure muscle, and niacin at those amounts can do the same, so together the risk adds up.
- Lovastatin can cause myopathy: muscle pain, tenderness or weakness with a large rise in the muscle enzyme creatine kinase (CK).
- The lovastatin label lists niacin at 1 gram a day or more among lipid-lowering drugs that raise the risk of myopathy because they can cause it on their own.
- The label groups niacin with lipid-lowering drugs that are not strong CYP3A4 blockers. The concern is two muscle effects adding together, not a higher lovastatin level.
- In rare cases muscle injury becomes rhabdomyolysis, where damaged muscle releases proteins that can harm the kidneys. The label says rare deaths have occurred with lovastatin.
- The label adds that in uncontrolled clinical studies, most patients who developed myopathy were also taking cyclosporine, gemfibrozil or niacin.
Why is this important?
This is a label warning, not a theory. The lovastatin label tells prescribers to use caution with lipid-lowering doses of niacin and to weigh the benefit of further changes in blood fats against the risks of the combination.
The size of the risk has not been measured with lovastatin itself. It was measured with simvastatin, another statin: in the HPS2-THRIVE trial, adding extended-release niacin raised definite myopathy about 4-fold, and muscle problems were more common in participants in China.
The extra risk also comes without a proven heart benefit. In two large trials of people already on a statin (simvastatin), adding niacin did not reduce heart attacks, strokes or other major vascular events. The lovastatin label also names age 65 or older and kidney problems as factors that call for extra care, which is why the decision belongs to your prescriber.
What should you do?
The principle is simple: cholesterol-dose niacin is a medicine decision, not a supplement add-on, when you take lovastatin.
Before starting niacin: If you take lovastatin and are thinking about a high-strength niacin product for cholesterol, talk to your prescriber first. Mention if you are 65 or older or have kidney problems.
Every day while on both: If your prescriber has decided the combination is right for you, take both exactly as prescribed and pay attention to your muscles, especially in the first weeks and after a dose increase of either one.
If symptoms appear: Contact your doctor promptly about unexplained muscle pain, tenderness or weakness, especially with fever, tiredness or dark urine. Do not stop or change lovastatin on your own; your doctor may check your CK level and decide what to change.
Which specific products are affected?
On the medication side, this applies to generic lovastatin tablets. Advicor, an older tablet that combined extended-release niacin with lovastatin in one pill, already contains both.
On the niacin side, the label warning is about niacin (nicotinic acid) at 1 gram a day or more. That includes prescription extended-release niacin (Niaspan and generics), immediate-release niacin, and high-strength over-the-counter niacin sold for cholesterol. The small amounts of niacin in a standard multivitamin or B-complex are far below that level. Niacinamide (nicotinamide), a different form of vitamin B3 found in many multivitamins and skin products, is not used to lower cholesterol and is not the form the label describes. Read the Supplement Facts label for the form and the amount per serving.
The science behind it
The lovastatin tablets prescribing information on DailyMed (Warnings, Myopathy/Rhabdomyolysis) says caution should be used when prescribing lipid-lowering doses of niacin (1 gram a day or more) with lovastatin, as these agents can cause myopathy when given alone, and that the benefit of further changes in lipid levels should be carefully weighed against the potential risks. Its Precautions section lists niacin among lipid-lowering drugs that are not strong CYP3A4 inhibitors but raise myopathy risk, and its Adverse Reactions section notes that in uncontrolled clinical studies most patients who developed myopathy were receiving cyclosporine, gemfibrozil or niacin.
The best measured rate comes from a different statin. In HPS2-THRIVE, 25,673 adults with vascular disease on simvastatin were randomized to extended-release niacin with laropiprant or placebo. Definite myopathy occurred in 75 people on niacin versus 17 on placebo (risk ratio 4.4), and any myopathy was more common in China (HPS2-THRIVE Collaborative Group, Eur Heart J 2013, PMID 23444397). Major vascular events did not fall (13.2 versus 13.7 percent) (N Engl J Med 2014, PMID 25014686), and in AIM-HIGH, adding niacin to simvastatin gave no extra benefit (N Engl J Med 2011, PMID 22085343).
Lovastatin and extended-release niacin were also studied together as a combined tablet. In a 52-week open-label study of 814 adults, no drug-induced myopathy occurred (Kashyap ML, et al. Am J Cardiol 2002, PMID 11897208), and an analysis of FDA adverse event reports from 1999 to 2005 found rhabdomyolysis reports for the combined tablet at rates similar to other statins or niacin alone (Alsheikh-Ali AA, Karas RH. Am J Cardiol 2007, PMID 17261402). A study of this size cannot rule out a rare muscle injury, and spontaneous reports cannot give a true rate. What was not shown: no randomized trial has measured the myopathy rate of niacin with lovastatin specifically, and the warning does not cover multivitamin amounts.
Frequently Asked Questions
Is the niacin in my multivitamin a problem with lovastatin?
The label warning is about niacin at 1 gram a day or more. Multivitamins contain far less. If you are unsure about a product, show the label to your pharmacist.
Why would anyone take niacin with a statin?
Niacin raises HDL cholesterol and lowers triglycerides, so it was once added to statins, and a combined niacin and lovastatin tablet was sold. In large trials, adding niacin to a statin did not reduce heart attacks or strokes and raised side effects, so it is now used far less.
Does slow-release or flush-free niacin avoid the problem?
Slow-release niacin does not: the large trial that measured the muscle risk used an extended-release form. Products sold as flush-free were not tested. Ask your pharmacist what form of niacin a product contains and how much.
Does niacin raise my lovastatin level?
The label does not describe that. It groups niacin with lipid-lowering drugs that are not strong CYP3A4 blockers; the concern is that niacin can harm muscle on its own, adding to lovastatin's effect.
What muscle symptoms should I watch for?
Unexplained muscle pain, tenderness or weakness, especially with fever, feeling unwell or dark urine. Contact your doctor promptly rather than waiting.
Is niacinamide the same as niacin?
No. Niacinamide is another form of vitamin B3 that is not used to lower cholesterol and is not the form the label warning describes.
Key takeaways
- Niacin at cholesterol-lowering amounts (1 gram a day or more) raises the risk of muscle injury with lovastatin, according to the lovastatin label.
- The label asks prescribers to use caution and weigh the benefit, because niacin can cause myopathy on its own.
- With simvastatin, adding extended-release niacin raised definite myopathy about 4-fold without reducing major vascular events.
- Multivitamin amounts of niacin, and niacinamide, are not what the warning is about.
- Report new muscle pain, weakness or dark urine promptly, and never change lovastatin on your own.
